Here's what's weighing down this biotech stock
July 24, 2015 at 10:40 AM EDT
Biogen shares sank heavily Friday after the biotech giant lowered its forecast for 2015 on slower-than-anticipated growth of its multiple sclerosis blockbuster Tecfidera.
